Ajmal Hussain

Stellantis Reports Significant Charges Amid Strategic Overhaul, Shares Plunge

Automaker anticipates full-year net loss and details €22 billion restructuring costs alongside strong Q4 shipments

Stellantis N.V. disclosed a comprehensive restructuring initiative that imposes approximately €22 billion in charges as the company aims to realign ...

Deputy Head of Russian Military Intelligence Seriously Injured in Moscow Shooting

Lt. Gen. Vladimir Alekseyev Shot and Hospitalized Amid Rising Attacks on Russian Military Leadership

On Friday, Lieutenant General Vladimir Alekseyev, the first deputy head of Russia's military intelligence agency (GRU), was shot multiple times by an ...

Visualizing Art Beyond Sight: A Photographer’s Unique Approach to Blindness and Sculpture

Using innovative long-exposure techniques, a Rome-based photographer captures how blind individuals experience art tactilely, inspired by Picasso's light trails.

A Rome-based photographer set out to explore how blind individuals perceive artworks, especially sculptures, through touch and other sensory experienc...

Woody Allen and Soon-Yi Previn's 2015 White House Visit Facilitated by Jeffrey Epstein

Newly Released Justice Department Emails Detail Allen's Connection With Epstein and Their Social Interactions

Documents recently made public by the Justice Department illuminate the relationship between filmmaker Woody Allen, his wife Soon-Yi Previn, and finan...

Google DeepMind CEO Sees Initial Signs of Slowing Junior Hiring Amid AI Advancements, No Widespread Job Losses Yet

While AI begins influencing recruitment dynamics, early labor market data shows gradual changes limited to entry-level roles rather than broad employment disruption

Artificial intelligence is starting to influence hiring practices, particularly affecting internships and entry-level positions, according to Google D...

Two Clinical Readouts and the Balance Sheet: A 2026 Trade Plan for Intellia (NTLA)

Positive Phase 1 data have reset expectations — but two binary catalysts will define 2026. Trade with defined risk, not hope.

Intellia is a CRISPR drug developer whose market moves in 2026 will hinge on clinical progress for two in-house ziclumeran programs and how the compan...

Hims & Hers Introduces Lower-Cost Oral Alternative to Wegovy Amid Legal Threats from Novo Nordisk

Novo Nordisk Prepares Legal Action Against Hims & Hers for Unapproved Semaglutide Product

Hims & Hers has announced a new, less expensive pill version of the weight-loss drug semaglutide, marketed as a competitor to Novo Nordisk's Wegovy. D...

Brand Engagement Network Sees Stock Rally Following Key Equity Agreement Termination

Strategic capital moves underscore company’s focus on disciplined growth and financial structure

Brand Engagement Network's shares rose significantly after the company ended a $50 million standby equity purchase arrangement, a decision intended to...

Treasury Secretary Scott Bessent Highlights Potential Chinese Development of Gold-Backed Digital Assets

Hong Kong’s Role as a Crucial Testing Hub for China’s Financial Innovation Explored

In testimony before the Senate Banking Committee, Treasury Secretary Scott Bessent discussed the possibility of China developing digital currency asse...

Hims & Hers Introduces Compounded Semaglutide Pill, Prompting Legal Threats from Novo Nordisk

Hims & Hers expands its weight loss treatment offerings with a new compounded semaglutide pill, while Novo Nordisk warns of potential legal repercussions

Hims & Hers Health Inc. has launched a compounded semaglutide pill as part of its weight loss specialty portfolio, providing customers with a more aff...